ASRAX | GRSRX | ASRAX / GRSRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 10 years | - |
Gain YTD | 1.899 | 2.932 | 65% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 390M | 1.79B | 22% |
Annual Yield % from dividends | 3.27 | 2.46 | 133% |
Returns for 1 year | 3.10 | 7.20 | 43% |
Returns for 3 years | -4.74 | -7.31 | 65% |
Returns for 5 years | -3.67 | -0.68 | 542% |
Returns for 10 years | 16.65 | 29.35 | 57% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EISDX | 24.03 | -0.17 | -0.70% |
Carillon ClariVest Intl Stock C | |||
NQCRX | 5.11 | -0.08 | -1.54% |
Nuveen Large Cap Value Opportunities I | |||
PAGSX | 64.66 | -1.15 | -1.75% |
T. Rowe Price Global Stock Adv | |||
TNRAX | 18.71 | -0.41 | -2.13% |
1290 Avantis U.S. Large Cap Growth A | |||
GSMQX | 19.18 | -0.70 | -3.52% |
Goldman Sachs Small/Mid Cap Growth Svc |